The Role of Liquid Biomarker for Early Detection of Prostate Cancer

Two experts in urology provide a discussion on currently available screening and risk assessment tools in prostate cancer and emphasize the importance of early detection.

EP1: Risk Assessment in Prostate Cancer: The PSA Test

June 10th 2021

Key opinion leaders in urology provide an overview of the prevalence of prostate cancer and discuss the importance of screening and risk assessment tools like the Prostate-Specific Antigen (PSA) test.

EP2: Screening Prostate Cancer with Blood and Urine Tests

June 10th 2021

Experts urologists, David Albala, MD and Judd W. Moul, MD, compare the utility of a variety of blood and urine tests for screening and diagnosing prostate cancer.

EP3: Challenges of Using MRI When Diagnosing Prostate Cancer

June 17th 2021

Thought leaders in the management of prostate cancer build a discussion on the challenges associated with the use of MRI to diagnose prostate cancer including insurance coverage and patient discomfort.

EP4: Blood and Urine Liquid Biopsy Tests in Prostate Cancer

June 17th 2021

Two experts in the management of prostate cancer provide key insight into the value of blood and urine liquid biopsy tests when deciding whether to perform a prostate tissue biopsy.

EP5: COVID-19: Telehealth and Compliance in Prostate Cancer

June 24th 2021

David Albala, MD and Judd W. Moul, MD consider the impact that COVID-19 has had on the clinical experience of patients with prostate cancer and share personal insights regarding telehealth and patient compliance.

EP6: Algorithms for Diagnostic Testing in Prostate Cancer

June 24th 2021

Key opinion leaders in urology review factors to consider when selecting screening and risk-assessment tests for the diagnosis of prostate cancer including insurance coverage, commercial availability, and patient preference.

EP7: Unmet Needs in the Early Detection of Prostate Cancer

July 1st 2021

Expert urologists remark on unmet needs in prostate cancer by emphasizing the importance of reaching under-served communities, addressing patient discomfort, increasing education about liquid biopsy testing, and standardizing prostate size assessment.

EP8: UroView: The Role of Liquid Biomarkers for Early Detection of Prostate Cancer

July 19th 2021

This article features insights from David Albala, MD, and Judd W. Moul, MD, on using liquid biomarker-based testing for the early detection of prostate cancer.